Cargando…
Low-dose rivaroxaban: can cardiovascular events be reduced?
Despite available effective guideline-based preventive therapies, patients with vascular diseases remain at high-risk of recurrent ischaemic events. Novel therapeutic strategies are therefore needed in order to further reduce the residual risk that is present in these high-risk patients. The Cardiov...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132608/ https://www.ncbi.nlm.nih.gov/pubmed/37125297 http://dx.doi.org/10.1093/eurheartjsupp/suad034 |